Administration of the PAR-2 antagonist exacerbated the decrease in body temperature during anaphylaxis in WT mice (Fig 5A) whereas administration of the PAR-2 antagonist did not affect the decrease in body temperature (Fig 5C). The gene discussed is F2RL1; the disease is anaphylaxis.